Bangalore- Indranil Sen, Chief Financial Officer (CFO) of Bengaluru-based Indian biopharmaceutical company Biocon, has resigned from his post effective from March 16, 2024.
Indranil obtained his Chartered Accountant qualification from the Institute of Chartered Accountants of India, New Delhi.
He joined Biocon 2014, after which he held various positions in the finance department. Mr Sen was appointed Chief Financial Officer (CFO) in April 2021 after Anupam Jindal stepped down from the post of CFO.
Indranil possesses more than two decades of extensive expertise in financial planning, treasury management, taxation, and financial reporting. His professional journey commenced in statutory audit, where he contributed to renowned firms such as B S R & Co. (the Indian division of KPMG) in Kolkata and S R Batliboi & Co. (the Indian branch of Ernst & Young) in Bengaluru.
Before joining Biocon, he held the position of Director of Finance at Symphony Teleca, a well-known multinational IT corporation headquartered in the United States.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.